- Page 2 and 3: ForewordMedication safety and provi
- Page 6 and 7: Chapter 6Conclusions and Recommenda
- Page 8 and 9: CHAPTER ONETHE WORKING GROUPMEMBERS
- Page 10 and 11: CHAPTER TWOTHE PROGRESS REPORT2.1 P
- Page 12 and 13: CHAPTER THREEAREAS FOR IMPROVEMENT
- Page 14 and 15: Existing In-patient Drug Administra
- Page 16 and 17: Existing In-patient Drug Administra
- Page 18 and 19: Existing In-patient Drug Administra
- Page 20 and 21: Existing In-patient Drug Administra
- Page 22 and 23: CHAPTER FOURRECOMMENDED PRACTICES A
- Page 24 and 25: Drug Name4.11 There should be a hos
- Page 26 and 27: Electronic prescribing (Medication
- Page 28 and 29: 4.46 When the use of CM is permitte
- Page 30 and 31: cytotoxic and central intravenous a
- Page 32 and 33: 4.72 Special precautions should be
- Page 34 and 35: 4.84 To prevent mixing up medicatio
- Page 36 and 37: The Principle of Three checks and F
- Page 38 and 39: 4.111 Three-way (red and blue) and
- Page 40 and 41: or their discharge or death, should
- Page 42 and 43: operational requirement but also it
- Page 44 and 45: Quality Complaints on Pharmaceutica
- Page 46 and 47: LEVELSHAHOCE / DTOOLS & MECHANISMDU
- Page 48 and 49: Medication Incident Report<
- Page 50 and 51: Continuing Education6.18 In order t
- Page 52 and 53: APPENDICESAppendix 1Appendix 2Appen
- Page 54 and 55:
Hospital Authority Hospital No. : I
- Page 56 and 57:
Sensitivity:Prescription/ routewith
- Page 58 and 59:
Appendix 3aLists of HA-wide Approve
- Page 60 and 61:
DRUGTeniposideABBREVIATIONVM-26Thia
- Page 62 and 63:
Appendix 3b“Do Not Use Abbreviati
- Page 64 and 65:
Appendix 4Schedule for the Administ
- Page 66 and 67:
Appendix 5Mechanism for the Managem
- Page 68 and 69:
4. As with all medications, there s
- Page 70 and 71:
Appendix 6HA Guideline on Safe Mana
- Page 72 and 73:
2.1 Concentrated potassium chloride
- Page 74 and 75:
Appendix 7Supply of Antidotes and D
- Page 76 and 77:
複 本 Antidotes and emeg drug lis
- Page 78 and 79:
Appendix 8Guidelines for Supply of
- Page 80 and 81:
substitution with other drugs in ac
- Page 82 and 83:
Appendix 9Samples of the Line Label
- Page 84 and 85:
Appendix 10Guidelines on the use of
- Page 86 and 87:
Appendix 11Guidelines on Patient Se
- Page 88 and 89:
Operational Guidelines7. The operat
- Page 90 and 91:
COC(N) Paper 12/2004Approved by COC
- Page 92 and 93:
7.4 Evaluation Record and report th
- Page 94 and 95:
DISPOSAL OF HOSPITAL PHARMACEUTICAL
- Page 96 and 97:
Appendix 14Guidelines on the Handli
- Page 98 and 99:
Appendix 15Medication Incident <str
- Page 100 and 101:
Hospital Authority Medication Incid
- Page 102 and 103:
QUALITY ASSURANCE IN DRUG THERAPYHO
- Page 104 and 105:
Fig. 1: ADR voluntary reporting sys
- Page 106 and 107:
PROCEUDRE FOR QUALITY COMPLAINTSONP
- Page 108:
Part II Procurement Section, CPO1.